A mouse model to evaluate the interface between skin and a percutaneous device

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 4, 2007, Pages 915-922

  Isenhath, S N ^a   Fukano, Y ^a   Usui, M L ^a   Underwood, R A ^a   Irvin, C A ^b   Marshall, A J ^b   Hauch, K D ^b   Ratner, B D ^b   Fleckman, P ^a   Olerud, J E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

Biointegration; Biomaterial; Implant; Poly(HEMA); Wound healing

Indexed keywords

BIOINTEGRATION; POLY(HEMA); WOUND HEALING;

BIOMATERIALS; BIOMEDICAL EQUIPMENT; DISEASE CONTROL; PHYSIOLOGICAL MODELS; SKIN; SURFACE TREATMENT;

BIOMEDICAL ENGINEERING;

2 OCTYL CYANOACRYLATE; BIOMATERIAL; CARBONYLDIIMIDAZOLE; CYANOACRYLATE DERIVATIVE; IMIDAZOLE DERIVATIVE; KALININ; POLYMACON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM; CELL INTERACTION; CELL INVASION; CONTROLLED STUDY; DEVICE; EPIDERMIS CELL; EVALUATION; HISTOLOGY; IMPLANT; IMPLANTATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SKIN; SKIN CELL; SKIN PENETRATION; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; MICE; MODELS, ANIMAL; POLYHYDROXYETHYL METHACRYLATE; SKIN; SKIN ABSORPTION;

EID: 36849017464     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31391     Document Type: Article

References (37)

1. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: Implications for preventive strategies. Medicine (Baltimore) 2002;81:466-479.
2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
3. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
4. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400-407.
5. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232-1242.
6. Knowles NG, Miyashita Y, Usui ML, Marshall AJ, Pirrone A, Hauch KD, Ratner BD, Underwood RA, Fleckman P, Olerud JE. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. J Biomed Mater Res A 2005;74:482-488.
7. Kunzker JF, McGee JA. Contact lens materials. Chem Indust 1995;16:56-60.
8. Fukano Y, Knowles NG, Usui ML, Underwood RA, Hauch KD, Marshall AJ, Ratner BD, Giachelli C, Carter WG, Fleckman P, et al. Characterization of an in vitro model for evaluating the interface between skin and percutaneous biomaterials. Wound Repair Regen 2006;14:484-491.
9. Marshall AJ, Irvin CA, Barker T, Sage EH, Hauch KD, Ratner BD. Biomaterials with tightly controlled poresize that promote vascular in-growth. Polym Preprints 2004;45:100-101.
10. Martin SM, Ganapathy R, Kim TK, Leach-Scampavia D, Giachelli CM, Ratner BD. Characterization and analysis of osteopontin-immobilized poly(2-hydroxyethyl methacrylate) surfaces. J Biomed Mater Res A 2003;67:334-343.
11. Gesler W, Smith R, DeDecker PG, Bernstam L, Snyder R, Freed PS, Kantrowitz A. Updated feasibility trial experience with the Viaderm percutaneous access device. ASAIO J 2004;50:349-353.
12. Snik AF, Bosman AJ, Mylanus EA, Cremers CW. Candidacy for the bone-anchored hearing aid. Audiol Neurootol 2004;9:190-196.
13. von Recum AF. Applications and failure modes of percutaneous devices: A review. J Biomed Mater Res 1984;18:323-336.
14. Heaney TG, Doherty PJ, Williams DF. Marsupialization of percutaneous implants in presence of deep connective tissue. J Biomed Mater Res 1996;32:593-601.
15. Jansen JA, van der Waerden JP, de Groot K. Development of a new percutaneous access device for implantation in soft tissues. J Biomed Mater Res 1991;25:1535-1545.
16. Winter GD. Transcutaneous implants: Reactions of the skin-implant interface. J Biomed Mater Res 1974;8:99-113.
17. Yu C, Sun Y, Bradfield J, Fiordalisi I, Harris GD. A novel percutaneous barrier device that permits safe subcutaneous access. ASAIO J 1999;45:531-534.
18. Kim H, Murakami H, Chehroudi B, Textor M, Brunette DM. Effects of surface topography on the connective tissue attachment to subcutaneous implants. Int J Oral Maxillofac Implants 2006;21:354-365.
19. Chehroudi B, Gould TR, Brunette DM. A light and electron microscopic study of the effects of surface topography on the behavior of cells attached to titanium-coated percutaneous implants. J Biomed Mater Res 1991;25:387-405.
20. Squier CA, Collins P. The relationship between soft tissue attachment, epithelial downgrowth and surface porosity. J Periodontal Res 1981;16:434-440.
21. Deporter DA, Shiga A, Melcher AH, Howley TP. The effect of bovine skin collagen (Zyderm) on the healing of experimental defects in rat calvarium. Prog Clin Biol Res 1985;187:353-363.
22. Fitton JH, Ziegelaar BW, Hicks CR, Clayton AB, Crawford GJ, Constable IJ, Chirila TV. Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea 1998;17:108-114.
23. Ryan MC, Lee K, Miyashita Y, Carter WG. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999;145:1309-1323.
24. Chehroudi B, Brunette DM. Subcutaneous microfabricated surfaces inhibit epithelial recession and promote long-term survival of percutaneous implants. Biomaterials 2002;23:229-237.
25. Narang U, Mainwaring L, Spath G, Barefoot J. In vitro analysis for microbial barrier properties of 2-octyl cyanoacrylate-derived wound treatment films. J Cutan Med Surg 2003;7:13-19.
26. Mertz PM, Davis SC, Cazzaniga AL, Drosou A, Eaglstein WH. Barrier and antibacterial properties of 2-octyl cyanoacrylate-derived wound treatment films. J Cutan Med Surg 2003;7:1-6.
27. Bhende S, Rothenburger S, Spangler DJ, Dito M. In vitro assessment of microbial barrier properties of Dermabond topical skin adhesive. Surg Infect (Larchmt) 2002;3:251-257.
28. Howell JM, Bresnahan KA, Stair TO, Dhindsa HS, Edwards BA. Comparison of effects of suture and cyanoacrylate tissue adhesive on bacterial counts in contaminated lacerations. Antimicrob Agents Chemother 1995;39:559-560.
29. Quinn J, Maw J, Ramotar K, Wenckebach G, Wells G. Octylcyanoacrylate tissue adhesive versus suture wound repair in a contaminated wound model. Surgery 1997;122:69-72.
30. Trott AT. Cyanoacrylate tissue adhesives. An advance in wound care. JAMA 1997;277:1559-1560.
31. Blondeel PN, Murphy JW, Debrosse D, Nix JC, III, Puls LE, Theodore N, Coulthard P. Closure of long surgical incisions with a new formulation of 2-octylcyanoacrylate tissue adhesive versus commercially available methods. Am J Surg 2004;188:307-313.
32. Hollander JE, Singer AJ. Laceration management. Ann Emerg Med 1999;34:356-367.
33. Quinn J, Wells G, Sutcliffe T, Jarmuske M, Maw J, Stiell I, Johns P. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA 1997;277:1527-1530.
34. Pachulski R, Sabbour H, Gupta R, Adkins D, Mirza H, Cone J. Cardiac device implant wound closure with 2-octyl cyanoacrylate. J Interv Cardiol 2005;18:185-187.
35. Singer AJ, Giordano P, Fitch JL, Gulla J, Ryker D, Chale S. Evaluation of a new high-viscosity octylcyanoacrylate tissue adhesive for laceration repair: A randomized, clinical trial. Acad Emerg Med 2003;10:1134-1137.
36. Bruns TB, Worthington JM. Using tissue adhesive for wound repair: A practical guide to dermabond. Am Fam Physician 2000;61:1383-1388.
37. Singer AJ, Hollander JE, Quinn JV. Evaluation and management of traumatic lacerations. N Engl J Med 1997;337:1142-1148.